Adjuvant Development for Vaccines and for Autoimmune and Allergic Diseases
This grant opportunity supports the development of vaccine adjuvants that enhance or modify immune responses for use in vaccines against infectious and immune-mediated diseases. The program is focused on improving pre-clinical adjuvant development to increase vaccine efficacy, especially for at-risk groups like children, the elderly, and the immunocompromised. The program allows Fast-Track and…
Source
Dates
Program & Phase
Keywords
Supporting Links
Documents
Similar Opportunities
-
NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed)
National Institutes of Health
-
Investigator-Initiated R01: Fully Remote mHealth Clinical Trials of Complementary and Integrative Interventions
National Institutes of Health
-
Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)
National Institutes of Health
-
Multiple Sclerosis Fellowship (Minnesota)
Mayo Clinic
-
DoW Autism Clinical Trial Award
Dept. of the Army -- USAMRAA
Find tens of thousands more opportunities — free
Scout accounts are free. Sign up to browse the full funding database, unlock the solicitation links and documents for this opportunity, and see how well each one fits your organization.
-
Tens of thousands of funding opportunities
Search and filter every grant and solicitation in Scout — all free, no credit card required.
-
Instant Fit Analysis
Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
-
Source links & full documents
Jump straight to the solicitation and download every attachment.
-
Save opportunities & track deadlines
Keep the opportunities that fit in one place and stay ahead of every due date.
Already have an account? Sign In
Trusted by 500+ Happy Customers